Search Results - "Ugarte, Manuel"

Global Perspective on the Impact of the COVID‐19 Pandemic on Rheumatology and Health Equity by Hsieh, Evelyn, Dey, Dzifa, Grainger, Rebecca, Li, Mengtao, Machado, Pedro M., Ugarte‐Gil, Manuel F., Yazdany, Jinoos

“…Although the public health emergency associated with the COVID‐19 pandemic has ended, challenges remain, especially for individuals with rheumatic diseases. We…”
Get full text

A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19 by Kim, Alfred H J, Sparks, Jeffrey A, Liew, Jean W, Putman, Michael S, Berenbaum, Francis, Duarte-García, Alí, Graef, Elizabeth R, Korsten, Peter, Sattui, Sebastian E, Sirotich, Emily, Ugarte-Gil, Manuel F, Webb, Kate, Grainger, Rebecca

“…Hydroxychloroquine, an essential treatment for many patients with rheumatologic conditions, has recently garnered widespread attention as a potential treatment…”
Get full text

SARS–CoV‐2 Infection and COVID‐19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta‐Analysis by Conway, Richard, Grimshaw, Alyssa A., Konig, Maximilian F., Putman, Michael, Duarte‐García, Alí, Tseng, Leslie Yingzhijie, Cabrera, Diego M., Chock, Yu Pei Eugenia, Degirmenci, Huseyin Berk, Duff, Eimear, Egeli, Bugra Han, Graef, Elizabeth R., Gupta, Akash, Harkins, Patricia, Hoyer, Bimba F., Jayatilleke, Arundathi, Jin, Shangyi, Kasia, Christopher, Khilnani, Aneka, Kilian, Adam, Kim, Alfred H. J., Lin, Chung Mun Alice, Low, Candice, Proulx, Laurie, Sattui, Sebastian E., Singh, Namrata, Sparks, Jeffrey A., Tam, Herman, Ugarte‐Gil, Manuel F., Ung, Natasha, Wang, Kaicheng, Wise, Leanna M., Yang, Ziyi, Young, Kristen J., Liew, Jean W., Grainger, Rebecca, Wallace, Zachary S., Hsieh, Evelyn

“…Objective The relative risk of SARS–CoV‐2 infection and COVID‐19 disease severity among people with rheumatic and musculoskeletal diseases (RMDs) compared to…”
Get full text

Applying the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Lupus Criteria to Patients From the LUMINA Cohort: Results From the Multiethnic, Multicenter US Cohort by Ugarte‐Gil, Manuel F., Pons‐Estel, Guillermo J., Harvey, Guillermina B., Vilá, Luis M., Griffin, Russell, Alarcón, Graciela S.

“…Objective To evaluate the performance of the 2019 European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) criteria…”
Get full text

Association of Systemic Lupus International Collaborating Clinics Frailty Index With Damage in Systemic Lupus Erythematosus Patients: Results From a Multiethnic, Multicenter US Cohort of Patients With Lupus by Ugarte‐Gil, Manuel F., Dubey, Jyoti, McGwin, Gerald, Reveille, John D., Vilá, Luis M., Alarcón, Graciela S.

“…Objective To evaluate the association between the Systemic Lupus International Collaborating Clinics frailty index (SLICC‐FI) and damage accrual in systemic…”
Get full text

Health‐Related Quality of Life in Adults With Adolescent‐ and Adult‐Onset Systemic Lupus Erythematosus: A Longitudinal Study of a Multiethnic US Cohort by Borgia, R. Ezequiel, Ugarte‐Gil, Manuel F., Vilá, Luis M., Reveille, John D., McGwin, Gerald, Alarcón, Graciela S.

“…Objective The long‐term impact of childhood‐onset systemic lupus erythematosus (SLE) on health‐related quality of life (HRQoL) in adult SLE patients in…”
Get full text

Measures of Fatigue in Patients With Rheumatic Diseases: A Critical Review by Elera‐Fitzcarrald, Claudia, Rocha, Judith, Burgos, Paula I., Ugarte‐Gil, Manuel F., Petri, Michelle, Alarcón, Graciela S.

Get full text

Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL) by Ugarte-Gil, Manuel Francisco, Wojdyla, Daniel, Pons-Estel, Guillermo J, Catoggio, Luis J, Drenkard, Cristina, Sarano, Judith, Berbotto, Guillermo A, Borba, Eduardo F, Sato, Emilia Inoue, Tavares Brenol, João C, Uribe, Oscar, Ramirez Gómez, Luis A, Guibert-Toledano, Marlene, Massardo, Loreto, Cardiel, Mario H, Silveira, Luis H, Chacón-Diaz, Rosa, Alarcón, Graciela S, Pons-Estel, Bernardo A

“…To evaluate disease activity statuses' (DAS') impact on systemic lupus erythematosus (SLE) outcomes. Four DAS were defined: remission off-therapy: SLE Disease…”
Get more information

Better Health‐Related Quality of Life in Systemic Lupus Erythematosus Predicted by Low Disease Activity State/Remission: Data From the Peruvian Almenara Lupus Cohort by Ugarte‐Gil, Manuel F., Gamboa‐Cárdenas, Rocío V., Reátegui‐Sokolova, Cristina, Medina‐Chinchón, Mariela, Zevallos, Francisco, Elera‐Fitzcarrald, Claudia, Pimentel‐Quiroz, Victor, Cucho‐Venegas, Jorge M., Rodríguez‐Bellido, Zoila, Pastor‐Asurza, César A., Alarcón, Graciela S., Perich‐Campos, Risto

“…Objective To determine if low disease activity state (LDAS)/remission predicts a better health‐related quality of life (HRQoL). Methods Patients with systemic…”
Get full text

Association Between Race/Ethnicity and COVID‐19 Outcomes in Systemic Lupus Erythematosus Patients From the United States: Data From the COVID‐19 Global Rheumatology Alliance by Ugarte‐Gil, Manuel F., Alarcón, Graciela S., Seet, Andrea M., Izadi, Zara, Montgomery, Anna D., Duarte‐García, Alí, Gilbert, Emily L., Valenzuela‐Almada, Maria O., Wise, Leanna, Sparks, Jeffrey A., Hsu, Tiffany Y.‐T., D'Silva, Kristin M., Patel, Naomi J., Sirotich, Emily, Liew, Jean W., Hausmann, Jonathan S., Sufka, Paul, Grainger, Rebecca, Bhana, Suleman, Wallace, Zachary, Jacobsohn, Lindsay, Strangfeld, Anja, Mateus, Elsa F., Hyrich, Kimme L., Gossec, Laure, Carmona, Loreto, Lawson‐Tovey, Saskia, Kearsley‐Fleet, Lianne, Schaefer, Martin, Machado, Pedro M., Robinson, Philip C., Gianfrancesco, Milena, Yazdany, Jinoos

“…Objective To determine the association between race/ethnicity and COVID‐19 outcomes in individuals with systemic lupus erythematosus (SLE). Methods Individuals…”
Get full text

The number of flares patients experience impacts on damage accrual in systemic lupus erythematosus: data from a multiethnic Latin American cohort by Ugarte-Gil, Manuel F, Acevedo-Vásquez, Eduardo, Alarcón, Graciela S, Pastor-Asurza, Cesar A, Alfaro-Lozano, José L, Cucho-Venegas, Jorge M, Segami, Maria I, Wojdyla, Daniel, Soriano, Enrique R, Drenkard, Cristina, Brenol, João Carlos, de Oliveira e Silva Montandon, Ana Carolina, Costallat, Lilian T Lavras, Massardo, Loreto, Molina-Restrepo, José F, Guibert-Toledano, Marlene, Silveira, Luis H, Amigo, Mary Carmen, Barile-Fabris, Leonor A, Chacón-Díaz, Rosa, Esteva-Spinetti, Maria H, Pons-Estel, Guillermo J, McGwin, Jr, Gerald, Pons-Estel, Bernardo A

“…To determine the association between the number of flares systemic lupus erythematosus (SLE) patients experience and damage accrual, independently of other…”
Get more information

Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19 by Sattui, Sebastian E, Liew, Jean W, Graef, Elizabeth R, Coler-Reilly, Ariella, Berenbaum, Francis, Duarte-García, Alí, Harrison, Carly, Konig, Maximilian F, Korsten, Peter, Putman, Michael S, Robinson, Philip C, Sirotich, Emily, Ugarte-Gil, Manuel F, Webb, Kate, Young, Kristen J, Kim, Alfred H J, Sparks, Jeffrey A

“…Several months into the COVID-19 pandemic, safe and effective treatments against this global health disaster have yet to be identified. Clinical research…”
Get more information

Incomplete Systemic Lupus Erythematosus: Early Diagnosis or Overdiagnosis? by Ugarte‐Gil, Manuel F., Alarcón, Graciela S.

Get full text

Is Low Disease Activity Sufficient as a Target in Systemic Lupus Erythematosus? Comment on the Article by Petri et al by Ugarte‐Gil, Manuel F., Wojdyla, Daniel, Pons‐Estel, Guillermo J., Pons‐Estel, Bernardo A., Alarcón, Graciela S.

Get full text

Zonulin, a marker of gut permeability, is associated with mortality in a cohort of hospitalised peruvian COVID-19 patients by Palomino-Kobayashi, Luciano A, Ymaña, Barbara, Ruiz, Joaquim, Mayanga-Herrera, Ana, Ugarte-Gil, Manuel F, Pons, Maria J

“…Zonulin has previously been related to intestinal permeability in various inflammatory diseases, and more recently to the physiopathology of severe COVID-19…”
Get full text

Disease features and outcomes in United States lupus patients of Hispanic origin and their Mestizo counterparts in Latin America: a commentary by Ugarte-Gil, Manuel F, Pons-Estel, Guillermo J, Molineros, Julio, Wojdyla, Daniel, McGwin, Jr, Gerald, Nath, Swapan K, Pons-Estel, Bernardo A, Alarcón-Riquelme, Marta, Alarcón, Graciela S

“…To evaluate disease features and outcomes in two populations with significant Amerindian ancestry. Hispanic patients (from Texas) from the Lupus in Minorities:…”
Get full text

Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population by Ponce de Leon, Dario, Acevedo-Vasquez, Eduardo, Alvizuri, Sergio, Gutierrez, Cesar, Cucho, Mariano, Alfaro, Jose, Perich, Risto, Sanchez-Torres, Alfredo, Pastor, Cesar, Sanchez-Schwartz, Cesar, Medina, Mariela, Gamboa, Rocio, Ugarte, Manuel

“…OBJECTIVE: Tuberculosis (TB) in patients with rheumatoid arthritis (RA) undergoing treatment with anti-tumor necrosis factor (TNF) agents is commonly the…”
Get full text

Corrigendum: Zonulin, a marker of gut permeability, is associated with mortality in a cohort of hospitalised peruvian COVID-19 patients by Palomino-Kobayashi, Luciano A, Ymaña, Barbara, Ruiz, Joaquim, Mayanga-Herrera, Ana, Ugarte-Gil, Manuel F, Pons, Maria J

“…[This corrects the article DOI: 10.3389/fcimb.2022.1000291.]…”
Get full text

Predictors of Remission and Low Disease Activity in Rheumatoid Arthritis Patients: Results From the Follow-up of a Real-World Peruvian Cohort by Gamboa-Cárdenas, Rocío-V., Ugarte-Gil, Manuel-F., Pimentel-Quiroz, Víctor, Reátegui -Sokolova, Cristina, Rodríguez-Bellido, Zoila, Zevallos-Miranda, Francisco, Medina-Chinchón, Mariela, Alfaro-Lozano, José, Noriega-Zapata, Erika, Cucho-Venegas, J. Mariano, Perich-Campos, Risto, Pastor-Asurza, César, Alarcón, Graciela S.

“…Clinical remission is the goal in rheumatoid arthritis (RA) management; however, this can be difficult to achieve in several parts of the world. Our objective…”
Get full text

Factors Predictive of High Disease Activity Early in the Course of SLE in Patients from a Latin-American Cohort by Pimentel-Quiroz, Victor R, Ugarte-Gil, Manuel F, Pons-Estel, Guillermo J, Soriano, Enrique R, Saurit, Verónica, Sato, Emilia I, Lavras Costallat, Lilian T, Molina, José Fernando, Gamarra, Antonio Iglesias, Reyes-Llerena, Gil, Neira, Oscar J, Barile, Leonor A, Silveira, Luis H, Segami, María Ines, Chacón-Díaz, Rosa, Wojdyla, Daniel, Alarcón, Graciela S, Pons-Estel, Bernardo A

“…Abstract Aims To determine the factors predictive of disease activity early in the course of SLE (baseline visit). Methods Patients from GLADEL, a…”
Get full text